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ABSTRACT 
In the adult brain, progenitor cells remaining in the subventricular zone (SVZ) are 
frequently identified as glial fibrillary acidic protein (GFAP)- positive cells that retain 
attributes reminiscent of radial glia. Because the very high expression of monoamine 
oxidase B (MAO-B) in the subventricular area has been related to epithelial and 
astroglial expression, we aimed to ascertain whether it was also expressed by progenitor 
cells of human control and Alzheimer’s disease (AD) patients. In the SVZ epithelial 
cells and astrocyte-like cells presented rich MAO-B activity and immunolabeling. 
Nestin-positive cells were found in the same area showing a radial-glia-like 
morphology. When co-immunostaining and confocal microscopy were performed, most 
nestin-positive cells showed MAO-B activity and labeling. The increased progenitor 
activity in SVZ proposed in AD patients was confirmed by the positive correlation 
between the SVZ nestin/MAO-B ratio and the progression of the disease. Nestin/GFAP 
positive cells, devoid of MAO-B can represent a distinct subpopulation of an earlier 
phase of maturation. This would indicate that MAO-B expression takes place in a 
further step of nestin/GFAP positive cells differentiation. In the early AD stages, the 
discrete MAO-B reduction, different from the severe GFAP decrease would reflect the 
capacity of this population of MAO-B positive progenitor cells to adapt to the 
neurodegenerative process. 
 
Keywords: Astroglia;  MAO-B;  Nestin;  Neural Stem cells;  neurogenesis. 
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INTRODUCTION 
Neural progenitor/stem cells characterized in adult human brain possess the 
characteristics of self-renewal, proliferation and differentiation along all major neural 
lineages. (Gross, 2000; Lie et al., 2004; Taupin, 2006). Their development progress in a 
permissive microenvironment and proceeds in several stages characterized by their 
morphology, and by gene expression of specific markers such as glial fibrillary acidic 
protein (GFAP) and the intermediate filament protein nestin (Garcia et al., 2004; Imura 
et al., 2003; Wei et al., 2002).  
In adult mammalian brain, germinal regions are the subventricular zone (SVZ) of the 
lateral ventricle and the subgranular zone within the dentate gyrus of the hippocampus 
and present abundant multipotent neural stem cells showing structural and biological 
markers of astroglia (Alvarez-Buylla and Garcia-Verdugo, 2002; Christie and Cameron, 
2006; Ihrie and Alvarez-Buylla, 2008). In rodent, SVZ is the source of new specific 
type of neurons destined to the olfactory bulb (Kornack and Rakic, 2001; Lledo et al., 
2008) and of oligondendrocytes during development (Levison and Goldman, 1993). 
Human SVZ also harbors abundant multipotent progenitor cells exhibiting markers of 
adult neurogenesis (Bernier et al., 2000; Bernier et al., 2002) that correspond to 
astrocytes (Doetsch et al., 1999; Sanai et al., 2004). In contrast to rodent, human SVZ 
astrocytes are not found adjacent to the ependymal layer, but forming a ribbon of cells 
lining the lateral ventricle, with no evidence of migrating neuroblasts (Quinones-
Hinojosa et al., 2006; Sanai et al., 2004). 
Basic questions regarding progenitor cell biology and mechanisms of differentiation 
remain open. As very few markers allow differentiating a multipotent radial-glia-like 
stem cell from a progenitor one, it remains difficult to identify with enough criteria their 
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future neuronal development. A better knowledge of the specific expression of each cell 
type is then needed to allow a clear discrimination.  
With regard to astroglial markers, expression of GFAP has been found in human adult 
SVZ progenitor cells whereas the S-100 presence is restricted to mature cells. 
However information concerning other well-identified astroglial markers remains 
elusive. Characterization of astroglial response based on monoamine oxidase B (MAO-
B; EC 1.4.3.4) expression has evidenced very high SVZ labeling in adult brain that 
could not be limited to epithelial and astroglial cells (Saura et al., 1997). With human 
aging, brain MAO-B activity increases progressively, beginning around the age of 50-
60 years (Kumar and Andersen, 2004; Saura et al., 1997), associated with increased 
astrogliosis. In Alzheimer’s disease (AD) patients a further increased SVZ MAO-B 
expression has been observed (Emilsson et al., 2002; Kennedy et al., 2003; Saura et al., 
1994), together with an increased SVZ progenitor activity associated with key 
pathological and neurochemical substrates (Ziabreva et al., 2006). In this study we 
investigated whether increased MAO-B expression in the SVZ of AD is related to 
endogenous proliferation and differentiation of progenitor cells. To help define the 
process of progenitor cell differentiation and begin approaching the underlying 
mechanisms present in neurodegenerative diseases, we investigated the specific 
expression of MAO-B in the SVZ and evaluated its relationship with specific progenitor 
cell and astrocyte markers in AD patients compared to age-matched controls.  
 
MATERIALS AND METHODS 
Human post-mortem brain tissue 
Human post-mortem tissue samples of SVZ of the lateral ventricle walls corresponded 
to the anterior horn and body of ventricle regions were selected for this study. They 
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5 
included the head and the body of caudate nucleus (Quinones-Hinojosa et al., 2006) and 
were obtained from our local Neurological Tissue Bank (Serveis Cientifico-Tècnics, 
Universitat de Barcelona, Barcelona, Spain) according to the European ethics guidelines 
and approved by the appropriated Research Ethics Committee. Brains were obtained at 
autopsy from individuals that suffered a clinical history of AD (n=7, stages II, V, VI, 
aged 79-91 years) and from non-demented controls (n=3, aged 44-74 years) (see Table 
1 for a summary of case histories). Neuropathological confirmation of the clinical 
diagnosis was undertaken at the Neurological Tissue Bank according to Braak and 
Newell criteria (Braak and Braak, 1991; Newell et al., 1999). The investigation was 
carried out on tissues that were either fresh-frozen and stored at -80ºC or paraffin-
embedded; 35 serial sections where obtained from each one of them. Sections thickness 
was 12 m for fresh-frozen tissue and 8 m for paraffin embedded tissue. All sections 
were mounted in slices (one section each) and used for histological and 
immunohistochemical procedures.  
Materials 
Clorgyline hydrochloride was purchased from Research Biochemicals Inc, (USA), the 
Immobilon-P membranes from Millipore (Bedford, MA) and the Lumi-Light enhanced 
chemiluminescence ECL from Roche Diagnostics (Mannheim, Germany). The rabbit 
anti-nestin polyclonal antibody was purchased from CHEMICON International 
(Temecula CA, USA), the mouse monoclonal anti-MHC II (HLA-DR) Ab-1 (Clone 
LN3) from Neomarkers (Fremont CA, USA), and the mouse monoclonal anti-A8-17 
was from DakoCytomation (Glostrup, Denmark). The mouse monoclonal anti-GFAP, 
the secondary antibodies and immunohistochemical reagents were from Sigma (St. 
Louis MO, USA, except for Alexa488 conjugated anti-rabbit IgG antibody and 
Page 5 of 53
Journal of Neuroscience Research
Journal of Neuroscience Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
6 
Alexa546 conjugated anti-mouse IgG antibody which were from Molecular Probes 
(Madrid, Spain).  
Western blot analysis of MAO-B  
Frozen 100 g samples from dissected SVZ or brain parenchyma were manually 
homogenized in 5 volumes of ice-cold Tris-HCl 50 mM, pH 7.7 and centrifuged at 
15000 rpm for 10 min, 4°C. The pellet was resuspended in ice cooled Tris-HCl and 
centrifuged twice more. The final pellet was resuspended in Tris-HCl incubation buffer. 
Protein content was determined by the method of Bradford using bovine serum albumin 
as standard. Western blot analysis was performed as previously described (Yeomanson 
and Billett, 1992) using the mouse monoclonal anti-MAO-B antibody 3F12/G10/2E3. 
Immobilon-P membranes were used for electroblotting. Blots were probed with anti-
MAO-B antibody (1:500, v/v) and binding was detected using an HRP-conjugated anti-
mouse IgG antibody. Incubation with no primary antibody was used to control the 
specificity of results. The immunocomplexes were developed using Lumi-Light ECL.  
Histology and immunohistochemistry 
Nissl staining was performed according to standard procedure with cresyl violet on four 
sections of every paraffin-embedded tissue. MAO-B histochemistry was performed 
according to Arai (Arai et al., 1986). Briefly, after washing with 0.01 M phosphate 
buffer saline (PBS), 5 cryostat sections of every fresh-frozen tissue were incubated in a 
reaction medium for 48 h at 4ºC. The medium consisted of 75 mg tyramine 
hydrochloride, 5 mg 3-3’-diaminobenzidine (DAB), 100 mg horseradish peroxidase, 
600 mg nickel ammonium sulphate and 10-6 M clorgyline hydrochloride for monoamine 
oxidase A inhibition. MAO-B activity appeared in the tissue sections as dark-blue 
precipitates.  
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7 
For nestin, GFAP, HLA-DR, and amyloid-beta (A immunohistochemistry analysis, 
12 serial paraffin-embedded SVZ sections of every brain sample were processed with 
the avidin-biotin peroxidase method. For A immunohistochemistry, sections were 
previously incubated with 98% formic acid for 3 min to enhance antigenicity. A 30-min 
preincubation in H2O2–methanol–PBS (0.3/9.7/90) was performed in all slices to inhibit 
non-specific staining in blood vessels and neurons. Sections were incubated at room 
temperature in blocking solution (0.01 M PBS + 3% normal goat serum, 0.1% Triton X-
100) for 2 h and separately incubated overnight at 4ºC with the primary antibody at the 
appropriated dilution in blocking solution. After washing and incubation with the 
appropriated biotinilated secondary antibody, sections were incubated with ExtrAvidin 
(1:250), and developed in DAB and H2O2. Some sections were counterstained with 
Mayer’s Haematoxylin.  
For MAO-B immunohistochemistry, sections were processed with the avidin-biotin 
peroxidase method with some modifications (Rodríguez et al., 2000). 3 serial 
consecutive frozen SVZ sections of every sample were post-fixed with acetone for 3 
min. at room temperature. After blocking endogenous peroxidases, sections were 
incubated for 30 min at room temperature in blocking solution containing normal pig 
serum. Overnight incubation was performed at 4ºC with mouse monoclonal anti-MAO-
B antibody (3F12/G10/2E3) (Yeomanson and Billett, 1992) diluted 1:50. Then, sections 
were processed as above described. In all cases, sections stained only with the 
secondary antibodies were used as negative controls.  
According to previous anatomical classification (Quinones-Hinojosa et al., 2006) four 
layers were observed throughout the SVZ: a monolayer of ependymal cells (Layer I), a 
hypocellular gap (Layer II), a ribbon of cells (Layer III) composed of astrocytes and a 
transitional zone (layer IV). These Layers I-IV were observed at the optic microscope 
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8 
and 4 areas of interest of 1.0 mm2 each were randomly selected to perform the cell 
number estimations at a x40 objective magnification. This counting procedure was 
performed by duplicate in three different sections of every case sample. Positive cells 
were counted in layers I-IV from the SVZ to the parenchyma boundary, and 
quantification was made using the Image Pro Plus v.5.1 image and analysis system 
(Media Cybernetics Inc., Bethesda, MD, USA).  
Double immunofluorescence was performed on 4 fresh-frozen and 4 paraffin-embedded 
SVZ sections of every sample. Sections were co-incubated overnight at 4ºC with anti-
nestin antibody and either anti-MAO-B antibody (fresh-frozen tissue), anti-GFAP 
antibody; or anti-HLA-DR antibody. After washing in PBS, sections were incubated in 
dark with a cocktail of Alexa488 conjugated anti-rabbit IgG antibody and Alexa546 
conjugated anti-mouse IgG antibody. Human brain autofluorescent lipofuscin artifacts 
were reduced to near background levels by immersion in 70% ethanol supplemented 
with 1% of Sudan black B for 5 min (Schnell et al., 1999). Sections were mounted in 
Immuno-Fluore Mounting medium (ICN Biomedicals, Barcelona, Spain) and examined 
with a Leica TCS-SL confocal microscope. Counting of double-stained cells was 
performed as above explained for single immunohistoch mistry procedures. Due to the 
antibody characteristics and difficult preservation of human sample integrity, no 
GFAP/MAO-B or GFAP/MAO-B/nestin co-localization could be performed. Because 
of that, to estimate the relationship between the three cell markers, a correlation analysis 
was performed and the ratios GFAP/MAO-B, Nestin/GFAP and Nestin/MAO-B were 
calculated from the cell counts assessed by single immunohistochemistry.  
Statistical analysis 
Kurtosis and Skewness moments were calculated to test the normal distribution of data. 
A one-way analysis of variance followed by the Fisher’s least significant difference 
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9 
analysis was performed to detect differences. Correlations between cell markers and the 
progression of AD were estimated by regression analysis between cell counts and a 
numerical value assigned to each AD stage. All values are presented as mean ± standard 
error of the mean (SD), and differences were considered to be significant at the P<0.05 
level. Data were analyzed with the statistical analysis package StatGraphics 5.0 (STSC 
Inc., Rockville, MD, USA). 
 
RESULTS 
Characterization of human SVZ 
In all control and AD cases, the anterior horn region and the body of the ventricle region 
of human SVZ presented a similar cellular organization (Figure 1a, b) as published 
elsewere (Quinones-Hinojosa et al., 2006). Ependymal cells were arranged as a one-cell 
thick epithelium forming Layer I. Layer II, an hypocellular region, formed a gap 
between Layer I and a dense ribbon of cell bodies (layer III of the SVZ) of different size 
and morphology. Layer IV was observed as a transitional zone to the striatal brain 
parenchyma.  
GFAP immunohistochemistry revealed an abundance of GFAP positive processes 
within the hypocellular layer, whereas layer III presented many GFAP positive cell 
bodies organized as a dense ribbon (Figure 1c). Their typical astrocyte morphology was 
associated with processes of irregular caliber with no specific orientation. In this area, 
control cases had a higher number of GFAP positive cells than AD cases (189  3 
cells/mm2 and 83  22 cells/mm2, respectively; P<0.0001) (Table 1 and Figure 2f). No 
correlation was found between GFAP-positive cell density and AD progression 
(P=0.123), but in all AD samples a dense population of well-delineated astrocytes 
appeared deep in parenchyma of caudate nucleus (data not shown). 
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10 
Nestin immunohistochemistry identified a dense population of polymorphic small cells, 
forming groups or short chains, mainly localized in layer III and parenchyma, and 
whose multiple short processes were oriented radially to the hypocellular layer (Figure 
1d). Other nestin positive cells had larger cell bodies and unipolar or multipolar 
organization with few or no visible processes. Small nestin positive cells were 
occasionally detected in layer II and the transitional zone (Layer IV), especially in AD 
cases. When control and AD cases were compared no significant increase in the density 
of nestin positive cells was found (159  1.7 cells/mm2 and 218  55 cells/mm2, 
respectively; P=0.139) (Table 1 and Figure 2e), but a positive correlation with AD 
progression was found (r2=0.593, P=0.038; figure 3) indicating an increase of 
progenitors during the course of the disease. Also, a significant increase of the 
Nestin/GFAP ratio between control and AD cases was observed (0.84  0.007 and 2.59 
 0.29 respectively, P=0.0013). However no relationship between Nestin and GFAP-
positive cell number alteration with AD progression were observed (fig 3a-b). 
In all samples, a few activated microglial cells were detected in layers III and IV, and 
also in the hypocellular layer (layer II) in controls and AD cases (figure 1e). No 
significant increase of HLA-DR positive cells was found in the SVZ when control and 
AD cases were compared (80.3  5.1 cells/mm2 and 78  1.0 cells/mm2, respectively;  
P=0.958, Figure 2h) and no correlation was found between microglial density and 
disease progression (P=0.937) nor between Nestin-positive cells and microglia in the 
SVZ (figure 3g-h). In contrast, stronger microglial activation with profusion of 
ramifications was observed in the brain parenchyma of AD cases (raw data not shown).  
In all control and AD cases, A protein deposition was mostly absent in layers I-IV of 
the SVZ (Figure 1f) with the exception of the stage VI AD cases, that present a few 
small amyloid deposits in layer III. Extracellular amyloid fibrils were also observed in 
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11 
layer III, in medium-sized and small wall arteries and arterioles of all AD samples (data 
not shown). 
MAO-B localization in the SVZ 
Quantitative MAO-B enzyme autoradiography (Saura et al., 1997) clearly showed that 
SVZ constitutes a human brain area rich in MAO-B (Figure 2a) but, due to the 
technique, no information on the cellular types expressing this enzyme was provided. In 
this paper, MAO-B cellular localization was characterized in the SVZ of all samples 
using three different methods. When histochemical procedures were performed, a 
typical MAO-B positive cell distribution in the cerebral area was found (Figure 2b). 
Positive MAO-B cells were mainly localized in Layer III of the SVZ, striatal brain 
parenchyma and subcortical white matter. In the SVZ, most MAO-B positive cells 
presented a stellate morphology, but positive processes were occasionally observed in 
layer II, parallel to the lateral wall of lateral ventricle (inset in figure 2b). Small 
proliferation of MAO-B positive cells was observed in layer II of samples of AD stage 
VI (data not shown). MAO-B positive cells were also detected by 
immunohistochemistry with similar cell morphology and distribution as described 
above for MAO-B histochemistry. MAO-B specific immunostaining was found in cells 
showing the morphology of astrocytes in the SVZ and in the cerebral parenchyma 
(Figure 2c). Parallel positive MAO-B processes were not detected, but instead positive 
fine punctuated cellular ramifications with no consistent orientation were observed. 
When MAO-B immunopositive cells were quantified, cell density was significantly 
decreased in the SVZ of all AD cases when compared with controls (mean density 118 
 1.7 cells/mm2 in controls and 96  7.1 in AD samples cells/mm2, P =0.0178) (Table 1, 
Figure 2e). This decrease did not correlate with AD stages progression (P=0.131). 
Western blot analysis of SVZ and caudate nucleus parenchyma evidenced a similar 
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12 
specific intensely band corresponding to MAO-B molecular weight (Figure 2d). The 
difficult preservation of SVZ integrity, caused by the post-mortem time, and tissue 
dissection render unreliable western blot quantification. 
When the GFAP/MAO-B ratio was studied a significant 43.7% decrease was found in 
AD cases when compared with controls (1.6  0.003 and 0.9  0.08 respectively, 
P=0.014) (Figure 3e-f), but no correlation with AD progression was detected (P=0.159) 
nor between GFAP and MAO-B cell counts. When the nestin/MAO-B ratio was 
analyzed, a significant 68% increase was found in AD cases when compared with 
controls (1.35  0.01 for controls and 2.27  0.23 for pathology, P= 0.013) (Figure 3c-
d). The correlation between this nestin/MAO-B ratio and the progression of the AD 
stages reached significance (P=0.025). Finally, the nestin/HLA-DR ratio revealed no 
difference and no correlation with AD progression (P=0.369 and P=0.066, respectively).  
 
Co-localization of SVZ markers 
Nestin-GFAP double confocal immunohistochemistry revealed the presence of 
abundant astrocyte-like cells in layer III and also a significant presence in layer IV, with 
cell processes or somata exhibiting both nestin- and GFAP-immunoreactivities. Double-
immunoreactive cell bodies had oval or fusiform shapes, and exhibited prominent, long 
slender processes that developed parallel to the wall of the lateral ventricle of anterior 
horn. In the body of ventricle, these processes appeared with no special organization. 
Nearly all nestin-positive cells expressed GFAP, and a major proportion of GFAP 
positive cells were also positive for nestin (Figure 4a-c). The few cells found positive 
for nestin with no astrocytic features were more abundant in the parenchyma, especially 
in stage VI of AD samples. 
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13 
In all control samples, double nestin-MAO-B immunohistochemistry revealed the 
presence of large cells with stellate morphology in layer III and in the hypocellular layer 
of the SVZ nearby blood vessels (Figure 4d-f). Some 35% of nestin-positive cells were 
also positive for MAO-B and a similar percent of MAO-B positive cells also expressed 
nestin. Fewer nestin/MAO-B-positive cells with a smaller round-shape were observed in 
AD samples. In all double-immunostained cells, labeling of nestin was mostly located 
in soma and MAO-B in soma and processes (Figure 4g-i), except in AD stage VI in 
which MAO-B was more localized in processes. Few double-immunostained round-
shape cells and unipolar and bipolar cells were also detected in the transitional zone and 
striatal parenchyma. Finally, nestin-immunoreactivity and HLA-DR-immunolabeling 
showed no co-localization. In the SVZ, HLA-DR positive cells were observed, mainly 
in layer III and IV. No spatial relationship between nestin-positive and HLA-DR-
positive cells was observed, except in AD samples where some HLA-DR positive cells 
surrounded nestin-positive cells (data not shown). 
 
DISCUSSION 
The present study gives evidence for the first time that MAO-B is expressed in SVZ 
progenitor cells of the human brain between 44 and 90 years. Morphological 
examination of the anterior horn and body of human lateral ventricle confirmed that 
adult human SVZ is organized into four specific layers (I-IV) with the SVZ astrocytes 
separated from the ependyma (I) by a hypocellular region (II) devoid of cells bodies. 
These astrocytes mainly localized in layer III, formed a cell ribbon before the 
transitional zone (IV) to parenchyma (Quinones-Hinojosa et al., 2006; Sanai et al., 
2004). Our data indicate an increase in progenitors in the SVZ during the course of AD. 
Neurogenesis in the SVZ is increased in acute neurological disorders, such as ischemia 
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14 
and epilepsy (Blumcke et al., 2001; Felling and Levison, 2003; Kokaia and Lindvall, 
2003) or in neurodegenerative disorders such as AD, Creutzfeldt-Jakob disease or brain 
tumors (Jackson and Alvarez-Buylla, 2008; Jin et al., 2004; Mizuno et al., 2006; 
Quinones-Hinojosa and Chaichana, 2007; Waldau and Shetty, 2008; Ziabreva et al., 
2006). In this study we found that expression of markers of radial cell differentiation is 
independent of neurodegeneration, in spite of the small deposition of Aprotein and 
microglial reaction present in layers I-IV of the germinal zone. 
According to previous immunohistochemical and enzyme-histochemical studies, 
MAO-B is localized in human brain astrocytes as well as in serotoninergic and 
histaminergic neurons of the raphe nuclei and posterior hypothalamus (Konradi et al., 
1988; Konradi et al., 1989). In this study, post-mortem delay ranged from 3 h to 19 h, 
and the sample time of storage prior to experiment ranged from 1 to 6 months. In these 
conditions, MAO-B remains a stable protein, and when present, its variation has been 
related with a cellular process. We and other authors have previously described a 
widespread increase of MAO-B expression in human brain aging, as a consequence of 
a general astroglial hypertrophy and/or hyperplasia (Nakamura et al., 1990; Saura et 
al., 1997; Saura et al., 1994). This astroglial up-regulation of MAO-B activity is 
closely related with AD senile plaques in cortical layers (Nakamura et al., 1990; Saura 
et al., 1997; Saura et al., 1994).  
However, the high expression of MAO-B in the SVZ in similar brain aging conditions, 
and its high level in ventricle ependyma, shown previously by quantitative MAO-B 
enzyme autoradiography (Saura et al., 1997) argue for a new cellular process, different 
from astrogliosis. Co-localization of MAO-B and nestin indicates the expression of a 
new marker of human adult SVZ, a zone that remains mitotically active in mammals 
throughout adult life (Alvarez-Buylla and Garcia-Verdugo, 2002; Merkle et al., 2004). 
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15 
The nestin/GFAP positive cells were abundant in SVZ layer III and organized as a 
continuous ribbon whereas nestin/MAO-B positive cells localized in layer III were less 
abundant and with no clear organization. Some nestin/MAO-B positive round-shaped 
cells and unipolar and bipolar cells were also detected in the transitional zone or layer 
IV of SVZ and brain parenchyma. In this portion of the germinal zone, MAO-B cellular 
localization appeared increased in the filaments in all the pathological cases, and more 
especially in the AD cases. The positive correlation between nestin/MAO B ratio and 
progression of the disease, and the increased nestin/GFAP ratio found in AD, could 
reflect the increased progenitor activity previously described in these patients (Ziabreva 
et al., 2006). Finally, the nestin positive cells lacking GFAP, that we found in SVZ and 
parenchyma in AD stage VI samples, could represent fully committed migrating 
neuroblasts (Kronenberg et al., 2003). 
GFAP and nestin have been the predominant markers used to describe stem and 
progenitor cells in mammalian CNS (Bernier et al., 2000; Doetsch et al., 1997; Doetsch 
et al., 1999; Ihrie and Alvarez-Buylla, 2008). In response to brain injury or 
degeneration, mature reactive GFAP positive astrocytes can express nestin and revert to 
embryonic phenotype of neuroepithelial stem cells (B rnier et al., 2000; Lin et al., 
1995). In our study, nearly all nestin-positive cells also express GFAP and but only 35% 
express MAO-B. The nestin/GFAP positive cells devoid of MAO-B may represent a 
distinct subpopulation that proliferates during an earlier phase of maturation. 
Dopamine-induced proliferation of precursor cells in the SVZ has been recently 
reported (O’Keeffe et al., 2009). As dopamine tissue content depends on MAO-B 
activity (Youdim et al., 2006), the increased MAO-B expression herein evidenced could 
be related to modulation of that progenitor cell proliferation. If true, MAO-B expression 
would take place in a further step of nestin/GFAP-positive cell maduration, to limit 
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16 
proliferation and facilitate the subsequent differentiation of progenitor cells. In the early 
AD stages, the increased nestin positive cells paralleled by a marked reduction of GFAP 
immunoreactivity evidences proliferation of progenitor cells and differentiation to 
neuroblasts (Kronenberg et al., 2003) or to newborn cells degenerated in the niche of 
germinal zone. In these conditions, the discrete MAO-B reduction, different from the 
severe GFAP decrease would reflect the capacity of progenitor cells to adapt to the 
neurodegenerative process at the SVZ level by increasing their differentiation rate. 
However, further investigation is required to decipher MAO-B participation in 
progenitor cells maturation and differentiation in control and neuropathological 
conditions. Anyhow, MAO-B labeling brings a new reliable tool for SVZ human stem 
cell study in control and pathological conditions. Finally, because of the marked 
differences between adult human and other vertebrates SVZ, our work highlights the 
importance of studying these cells in the human brain, especially when related to CNS 
diseases. 
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FIGURE LEGENDS  
Figure 1: Histological characterization of human SVZ in AD cases. (a, b) AD stage VI; 
Nissl staining showed the anterior horn region and body of ventricle region with a 
characteristic layer organization. The ependymal cells formed layer I, whereas layer II, 
a hypocellular region formed a gap with layer III that was organized as a dense ribbon 
of cell bodies. Finally layer IV represented a transitional zone to the striatal brain 
parenchyma. c) AD stage II; GFAP immunostaining of showed layer II as the most 
GFAP-immunoreactive area, with the GFAP immunopositive cell bodies localized in 
layer III. d) AD stage VI; nestin immunopositive cells were localized mainly in layer III 
(arrowheads) sometimes formed small chains, with short processes oriented radially to 
the hypocellular layer. e) AD stage II; scarcely activated microglial cells detected by 
HLA-DR immunohistochemistry were found mainly in the layer II (arrowhead). 
Microglial positive cells were also detected in the trans tional zone (asterisk) (Layer IV) 
and brain parenchyma. f) AD stage II; cerebral A protein deposition was practically 
absent in the human SVZ, except in AD stage VI cases where small amyloid deposits 
were detected in layer III. In AD cases amyloid-beta deposition was abundantly present 
in the brain parenchyma. LV: Lateral ventricle. Scale bar: a-e 50 m;  f, 200 m  
 
Figure 2: Evidences of MAO-B localization in the SVZ of AD cases. (a) Quantitative 
[3H]lazabemide in vitro autoradiography of human basal ganglia samples evidenced the 
highest brain MAO-B labeling in the SVZ (arrow) (Results extracted from Saura et al. 
1997). (b) AD stage V; histochemistry showed MAO-B activity labeling in the SVZ, 
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23 
especially in astrocytes of layer III (arrows and inset). (c) AD stage V; MAO-B 
immunohistochemistry counterstained with haematoxylin (cellular nuclei stained in 
blue) in the SVZ and parenchyma evidenced MAO-B staining (brown) in the cells with 
astrocyte morphology. (d) MAO-B western blot analysis of the SVZ and striatal 
parenchyma (parem) brain samples. (e-h) Scater plot and histograms of cell counts from 
the different markers included in the study, in control subjects (n= 3) and AD subjects 
(n= 7). Note the different AD-induced change between Nestin positive cell count and 
GFAP or MAO-B positive cell counts. LV: Lateral ventricle. AD, Alzheimer’s disease. 
Scale bars: a, 3 mm, b, 50 m; c and inset in b, 15 m * p< 0.05;  ** p<0.01;  *** 
p<0.001 vs. control (LSD post-hoc). 
 
Figure 3: Estimation of the AD changes in the relationship between Nestin, GFAP, 
MAO-B, and HLA-DR positive cell counts in the SVZ. The ratio estimation and 
dispersion plot of Nestin/GFAP (a,b), Nestin/MAO-B (c,d), GFAP/MAO-B (e,f), and 
Nestin/HLA-DR (g,h) immunopositive cells evidenced an AD-associated decrease of 
GFAP-immunopositive cells with respect to both Nestin and MAO-B positive cells. 
Please note an AD-stage associated increase of nestin positive cells (r2=0.593, p= 
0.038) in dispersion plots b, d and h. AD, Alzheimer’s disease; Stage II and Stage V-VI 
refers to Stages of AD cases. * p< 0.05; vs. control (LSD post-hoc). 
 
Figure 4: Co-localization of SVZ markers of AD cases. (a-c) AD stage V; the double 
confocal immunohistochemistry of body of ventricle showing GFAP in green and nestin 
in red, revealed the presence of oval or fusiform astrocyte-like cells mostly in layer III 
(merge), with positive large and extensive with no special organization. (d-f) AD stage 
VI; the double confocal nestin (red) / MAO-B (green) immunohistochemistry revealed 
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24 
the presence of round-shape cells and unipolar and bipolar cells in layer III and the 
transitional zone and striatal brain parenchyma (merge) especially in AD samples. (g-i) 
In control samples the presence of nestin (red) / MAO-B (green) positive large cells 
with stellate morphology were detected in layer III and in the hypocellular layer nearby 
blood vessels (merge). Scale bar:a-fm;  g-i, 16 m.  
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ABSTRACT 
In the adult brain, progenitor cells remaining in the subventricular zone (SVZ) are 
frequently identified as glial fibrillary acidic protein (GFAP)- positive cells that retain 
attributes reminiscent of radial glia. Because the very high expression of monoamine 
oxidase B (MAO-B) in the subventricular area has been related to epithelial and 
astroglial expression, we aimed to ascertain whether it was also expressed by progenitor 
cells of human control and Alzheimer’s disease (AD) patients. In the SVZ epithelial 
cells and astrocyte-like cells presented rich MAO-B activity and immunolabeling. 
Nestin-positive cells were found in the same area showing a radial-glia-like 
morphology. When co-immunostaining and confocal microscopy were performed, most 
nestin-positive cells showed MAO-B activity and labeling. The increased progenitor 
activity in SVZ proposed in AD patients was confirmed by the positive correlation 
between the SVZ nestin/MAO-B ratio and the progression of the disease. Nestin/GFAP 
positive cells, devoid of MAO-B can represent a distinct subpopulation of an earlier 
phase of maturation. This would indicate that MAO-B expression takes place in a 
further step of nestin/GFAP positive cells differentiation. In the early AD stages, the 
discrete MAO-B reduction, different from the severe GFAP decrease would reflect the 
capacity of this population of MAO-B positive progenitor cells to adapt to the 
neurodegenerative process. 
 
Keywords: Astroglia;  MAO-B;  Nestin;  Neural Stem cells;  neurogenesis. 
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3 
INTRODUCTION 
Neural progenitor/stem cells characterized in adult human brain possess the 
characteristics of self-renewal, proliferation and differentiation along all major neural 
lineages. (Gross, 2000; Lie et al., 2004; Taupin, 2006). Their development progress in a 
permissive microenvironment and proceeds in several stages characterized by their 
morphology, and by gene expression of specific markers such as glial fibrillary acidic 
protein (GFAP) and the intermediate filament protein nestin (Garcia et al., 2004; Imura 
et al., 2003; Wei et al., 2002).  
In adult mammalian brain, germinal regions are the subventricular zone (SVZ) of the 
lateral ventricle and the subgranular zone within the dentate gyrus of the hippocampus 
and present abundant multipotent neural stem cells showing structural and biological 
markers of astroglia (Alvarez-Buylla and Garcia-Verdugo, 2002; Christie and Cameron, 
2006; Ihrie and Alvarez-Buylla, 2008). In rodent, SVZ is the source of new specific 
type of neurons destined to the olfactory bulb (Kornack and Rakic, 2001; Lledo et al., 
2008) and of oligondendrocytes during development (Levison and Goldman, 1993). 
Human SVZ also harbors abundant multipotent progenitor cells exhibiting markers of 
adult neurogenesis (Bernier et al., 2000; Bernier et al., 2002) that correspond to 
astrocytes (Doetsch et al., 1999; Sanai et al., 2004). In contrast to rodent, human SVZ 
astrocytes are not found adjacent to the ependymal layer, but forming a ribbon of cells 
lining the lateral ventricle, with no evidence of migrating neuroblasts (Quinones-
Hinojosa et al., 2006; Sanai et al., 2004). 
Basic questions regarding progenitor cell biology and mechanisms of differentiation 
remain open. As very few markers allow differentiating a multipotent radial-glia-like 
stem cell from a progenitor one, it remains difficult to identify with enough criteria their 
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4 
future neuronal development. A better knowledge of the specific expression of each cell 
type is then needed to allow a clear discrimination.  
With regard to astroglial markers, expression of GFAP has been found in human adult 
SVZ progenitor cells whereas the S-100 presence is restricted to mature cells. 
However information concerning other well-identified astroglial markers remains 
elusive. Characterization of astroglial response based on monoamine oxidase B (MAO-
B; EC 1.4.3.4) expression has evidenced very high SVZ labeling in adult brain that 
could not be limited to epithelial and astroglial cells (Saura et al., 1997). With human 
aging, brain MAO-B activity increases progressively, beginning around the age of 50-
60 years (Kumar and Andersen, 2004; Saura et al., 1997), associated with increased 
astrogliosis. In Alzheimer’s disease (AD) patients a further increased SVZ MAO-B 
expression has been observed (Emilsson et al., 2002; Kennedy et al., 2003; Saura et al., 
1994), together with an increased SVZ progenitor activity associated with key 
pathological and neurochemical substrates (Ziabreva et al., 2006). In this study we 
investigated whether increased MAO-B expression in the SVZ of AD is related to 
endogenous proliferation and differentiation of progenitor cells. To help define the 
process of progenitor cell differentiation and begin approaching the underlying 
mechanisms present in neurodegenerative diseases, we investigated the specific 
expression of MAO-B in the SVZ and evaluated its relationship with specific progenitor 
cell and astrocyte markers in AD patients compared to age-matched controls.  
 
MATERIALS AND METHODS 
Human post-mortem brain tissue 
Human post-mortem tissue samples of SVZ of the lateral ventricle walls corresponded 
to the anterior horn and body of ventricle regions were selected for this study. They 
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5 
included the head and the body of caudate nucleus (Quinones-Hinojosa et al., 2006) and 
were obtained from our local Neurological Tissue Bank (Serveis Cientifico-Tècnics, 
Universitat de Barcelona, Barcelona, Spain) according to the European ethics guidelines 
and approved by the appropriated Research Ethics Committee. Brains were obtained at 
autopsy from individuals that suffered a clinical history of AD (n=7, stages II, V, VI, 
aged 79-91 years) and from non-demented controls (n=3, aged 44-74 years) (see Table 
1 for a summary of case histories). Neuropathological confirmation of the clinical 
diagnosis was undertaken at the Neurological Tissue Bank according to Braak and 
Newell criteria (Braak and Braak, 1991; Newell et al., 1999). The investigation was 
carried out on tissues that were either fresh-frozen and stored at -80ºC or paraffin-
embedded; 35 serial sections where obtained from each one of them. Sections thickness 
was 12 m for fresh-frozen tissue and 8 m for paraffin embedded tissue. All sections 
were mounted in slices (one section each) and used for histological and 
immunohistochemical procedures.  
Materials 
Clorgyline hydrochloride was purchased from Research Biochemicals Inc, (USA), the 
Immobilon-P membranes from Millipore (Bedford, MA) and the Lumi-Light enhanced 
chemiluminescence ECL from Roche Diagnostics (Mannheim, Germany). The rabbit 
anti-nestin polyclonal antibody was purchased from CHEMICON International 
(Temecula CA, USA), the mouse monoclonal anti-MHC II (HLA-DR) Ab-1 (Clone 
LN3) from Neomarkers (Fremont CA, USA), and the mouse monoclonal anti-A8-17 
was from DakoCytomation (Glostrup, Denmark). The mouse monoclonal anti-GFAP, 
the secondary antibodies and immunohistochemical reagents were from Sigma (St. 
Louis MO, USA, except for Alexa488 conjugated anti-rabbit IgG antibody and 
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6 
Alexa546 conjugated anti-mouse IgG antibody which were from Molecular Probes 
(Madrid, Spain).  
Western blot analysis of MAO-B  
Frozen 100 g samples from dissected SVZ or brain parenchyma were manually 
homogenized in 5 volumes of ice-cold Tris-HCl 50 mM, pH 7.7 and centrifuged at 
15000 rpm for 10 min, 4°C. The pellet was resuspended in ice cooled Tris-HCl and 
centrifuged twice more. The final pellet was resuspended in Tris-HCl incubation buffer. 
Protein content was determined by the method of Bradford using bovine serum albumin 
as standard. Western blot analysis was performed as previously described (Yeomanson 
and Billett, 1992) using the mouse monoclonal anti-MAO-B antibody 3F12/G10/2E3. 
Immobilon-P membranes were used for electroblotting. Blots were probed with anti-
MAO-B antibody (1:500, v/v) and binding was detected using an HRP-conjugated anti-
mouse IgG antibody. Incubation with no primary antibody was used to control the 
specificity of results. The immunocomplexes were developed using Lumi-Light ECL.  
Histology and immunohistochemistry 
Nissl staining was performed according to standard procedure with cresyl violet on four 
sections of every paraffin-embedded tissue. MAO-B histochemistry was performed 
according to Arai (Arai et al., 1986). Briefly, after washing with 0.01 M phosphate 
buffer saline (PBS), 5 cryostat sections of every fresh-frozen tissue were incubated in a 
reaction medium for 48 h at 4ºC. The medium consisted of 75 mg tyramine 
hydrochloride, 5 mg 3-3’-diaminobenzidine (DAB), 100 mg horseradish peroxidase, 
600 mg nickel ammonium sulphate and 10-6 M clorgyline hydrochloride for monoamine 
oxidase A inhibition. MAO-B activity appeared in the tissue sections as dark-blue 
precipitates.  
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7 
For nestin, GFAP, HLA-DR, and amyloid-beta (A immunohistochemistry analysis, 
12 serial paraffin-embedded SVZ sections of every brain sample were processed with 
the avidin-biotin peroxidase method. For A immunohistochemistry, sections were 
previously incubated with 98% formic acid for 3 min to enhance antigenicity. A 30-min 
preincubation in H2O2–methanol–PBS (0.3/9.7/90) was performed in all slices to inhibit 
non-specific staining in blood vessels and neurons. Sections were incubated at room 
temperature in blocking solution (0.01 M PBS + 3% normal goat serum, 0.1% Triton X-
100) for 2 h and separately incubated overnight at 4ºC with the primary antibody at the 
appropriated dilution in blocking solution. After washing and incubation with the 
appropriated biotinilated secondary antibody, sections were incubated with ExtrAvidin 
(1:250), and developed in DAB and H2O2. Some sections were counterstained with 
Mayer’s Haematoxylin.  
For MAO-B immunohistochemistry, sections were processed with the avidin-biotin 
peroxidase method with some modifications (Rodríguez et al., 2000). 3 serial 
consecutive frozen SVZ sections of every sample were post-fixed with acetone for 3 
min. at room temperature. After blocking endogenous peroxidases, sections were 
incubated for 30 min at room temperature in blocking solution containing normal pig 
serum. Overnight incubation was performed at 4ºC with mouse monoclonal anti-MAO-
B antibody (3F12/G10/2E3) (Yeomanson and Billett, 1992) diluted 1:50. Then, sections 
were processed as above described. In all cases, sections stained only with the 
secondary antibodies were used as negative controls.  
According to previous anatomical classification (Quinones-Hinojosa et al., 2006) four 
layers were observed throughout the SVZ: a monolayer of ependymal cells (Layer I), a 
hypocellular gap (Layer II), a ribbon of cells (Layer III) composed of astrocytes and a 
transitional zone (layer IV). These Layers I-IV were observed at the optic microscope 
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8 
and 4 areas of interest of 1.0 mm2 each were randomly selected to perform the cell 
number estimations at a x40 objective magnification. This counting procedure was 
performed by duplicate in three different sections of every case sample. Positive cells 
were counted in layers I-IV from the SVZ to the parenchyma boundary, and 
quantification was made using the Image Pro Plus v.5.1 image and analysis system 
(Media Cybernetics Inc., Bethesda, MD, USA).  
Double immunofluorescence was performed on 4 fresh-frozen and 4 paraffin-embedded 
SVZ sections of every sample. Sections were co-incubated overnight at 4ºC with anti-
nestin antibody and either anti-MAO-B antibody (fresh-frozen tissue), anti-GFAP 
antibody; or anti-HLA-DR antibody. After washing in PBS, sections were incubated in 
dark with a cocktail of Alexa488 conjugated anti-rabbit IgG antibody and Alexa546 
conjugated anti-mouse IgG antibody. Human brain autofluorescent lipofuscin artifacts 
were reduced to near background levels by immersion in 70% ethanol supplemented 
with 1% of Sudan black B for 5 min (Schnell et al., 1999). Sections were mounted in 
Immuno-Fluore Mounting medium (ICN Biomedicals, Barcelona, Spain) and examined 
with a Leica TCS-SL confocal microscope. Counting of double-stained cells was 
performed as above explained for single immunohistoch mistry procedures. Due to the 
antibody characteristics and difficult preservation of human sample integrity, no 
GFAP/MAO-B or GFAP/MAO-B/nestin co-localization could be performed. Because 
of that, to estimate the relationship between the three cell markers, a correlation analysis 
was performed and the ratios GFAP/MAO-B, Nestin/GFAP and Nestin/MAO-B were 
calculated from the cell counts assessed by single immunohistochemistry.  
Statistical analysis 
Kurtosis and Skewness moments were calculated to test the normal distribution of data. 
A one-way analysis of variance followed by the Fisher’s least significant difference 
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9 
analysis was performed to detect differences. Correlations between cell markers and the 
progression of AD were estimated by regression analysis between cell counts and a 
numerical value assigned to each AD stage. All values are presented as mean ± standard 
error of the mean (SD), and differences were considered to be significant at the P<0.05 
level. Data were analyzed with the statistical analysis package StatGraphics 5.0 (STSC 
Inc., Rockville, MD, USA). 
 
RESULTS 
Characterization of human SVZ 
In all control and AD cases, the anterior horn region and the body of the ventricle region 
of human SVZ presented a similar cellular organization (Figure 1a, b) as published 
elsewere (Quinones-Hinojosa et al., 2006). Ependymal cells were arranged as a one-cell 
thick epithelium forming Layer I. Layer II, an hypocellular region, formed a gap 
between Layer I and a dense ribbon of cell bodies (layer III of the SVZ) of different size 
and morphology. Layer IV was observed as a transitional zone to the striatal brain 
parenchyma.  
GFAP immunohistochemistry revealed an abundance of GFAP positive processes 
within the hypocellular layer, whereas layer III presented many GFAP positive cell 
bodies organized as a dense ribbon (Figure 1c). Their typical astrocyte morphology was 
associated with processes of irregular caliber with no specific orientation. In this area, 
control cases had a higher number of GFAP positive cells than AD cases (189  3 
cells/mm2 and 83  22 cells/mm2, respectively; P<0.0001) (Table 1 and Figure 2f). No 
correlation was found between GFAP-positive cell density and AD progression 
(P=0.123), but in all AD samples a dense population of well-delineated astrocytes 
appeared deep in parenchyma of caudate nucleus (data not shown). 
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10 
Nestin immunohistochemistry identified a dense population of polymorphic small cells, 
forming groups or short chains, mainly localized in layer III and parenchyma, and 
whose multiple short processes were oriented radially to the hypocellular layer (Figure 
1d). Other nestin positive cells had larger cell bodies and unipolar or multipolar 
organization with few or no visible processes. Small nestin positive cells were 
occasionally detected in layer II and the transitional zone (Layer IV), especially in AD 
cases. When control and AD cases were compared no significant increase in the density 
of nestin positive cells was found (159  1.7 cells/mm2 and 218  55 cells/mm2, 
respectively; P=0.139) (Table 1 and Figure 2e), but a positive correlation with AD 
progression was found (r2=0.593, P=0.038; figure 3) indicating an increase of 
progenitors during the course of the disease. Also, a significant increase of the 
Nestin/GFAP ratio between control and AD cases was observed (0.84  0.007 and 2.59 
 0.29 respectively, P=0.0013). However no relationship between Nestin and GFAP-
positive cell number alteration with AD progression were observed (fig 3a-b). 
In all samples, a few activated microglial cells were detected in layers III and IV, and 
also in the hypocellular layer (layer II) in controls and AD cases (figure 1e). No 
significant increase of HLA-DR positive cells was found in the SVZ when control and 
AD cases were compared (80.3  5.1 cells/mm2 and 78  1.0 cells/mm2, respectively;  
P=0.958, Figure 2h) and no correlation was found between microglial density and 
disease progression (P=0.937) nor between Nestin-positive cells and microglia in the 
SVZ (figure 3g-h). In contrast, stronger microglial activation with profusion of 
ramifications was observed in the brain parenchyma of AD cases (raw data not shown).  
In all control and AD cases, A protein deposition was mostly absent in layers I-IV of 
the SVZ (Figure 1f) with the exception of the stage VI AD cases, that present a few 
small amyloid deposits in layer III. Extracellular amyloid fibrils were also observed in 
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11 
layer III, in medium-sized and small wall arteries and arterioles of all AD samples (data 
not shown). 
MAO-B localization in the SVZ 
Quantitative MAO-B enzyme autoradiography (Saura et al., 1997) clearly showed that 
SVZ constitutes a human brain area rich in MAO-B (Figure 2a) but, due to the 
technique, no information on the cellular types expressing this enzyme was provided. In 
this paper, MAO-B cellular localization was characterized in the SVZ of all samples 
using three different methods. When histochemical procedures were performed, a 
typical MAO-B positive cell distribution in the cerebral area was found (Figure 2b). 
Positive MAO-B cells were mainly localized in Layer III of the SVZ, striatal brain 
parenchyma and subcortical white matter. In the SVZ, most MAO-B positive cells 
presented a stellate morphology, but positive processes were occasionally observed in 
layer II, parallel to the lateral wall of lateral ventricle (inset in figure 2b). Small 
proliferation of MAO-B positive cells was observed in layer II of samples of AD stage 
VI (data not shown). MAO-B positive cells were also detected by 
immunohistochemistry with similar cell morphology and distribution as described 
above for MAO-B histochemistry. MAO-B specific immunostaining was found in cells 
showing the morphology of astrocytes in the SVZ and in the cerebral parenchyma 
(Figure 2c). Parallel positive MAO-B processes were not detected, but instead positive 
fine punctuated cellular ramifications with no consistent orientation were observed. 
When MAO-B immunopositive cells were quantified, cell density was significantly 
decreased in the SVZ of all AD cases when compared with controls (mean density 118 
 1.7 cells/mm2 in controls and 96  7.1 in AD samples cells/mm2, P =0.0178) (Table 1, 
Figure 2e). This decrease did not correlate with AD stages progression (P=0.131). 
Western blot analysis of SVZ and caudate nucleus parenchyma evidenced a similar 
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12 
specific intensely band corresponding to MAO-B molecular weight (Figure 2d). The 
difficult preservation of SVZ integrity, caused by the post-mortem time, and tissue 
dissection render unreliable western blot quantification. 
When the GFAP/MAO-B ratio was studied a significant 43.7% decrease was found in 
AD cases when compared with controls (1.6  0.003 and 0.9  0.08 respectively, 
P=0.014) (Figure 3e-f), but no correlation with AD progression was detected (P=0.159) 
nor between GFAP and MAO-B cell counts. When the nestin/MAO-B ratio was 
analyzed, a significant 68% increase was found in AD cases when compared with 
controls (1.35  0.01 for controls and 2.27  0.23 for pathology, P= 0.013) (Figure 3c-
d). The correlation between this nestin/MAO-B ratio and the progression of the AD 
stages reached significance (P=0.025). Finally, the nestin/HLA-DR ratio revealed no 
difference and no correlation with AD progression (P=0.369 and P=0.066, respectively).  
 
Co-localization of SVZ markers 
Nestin-GFAP double confocal immunohistochemistry revealed the presence of 
abundant astrocyte-like cells in layer III and also a significant presence in layer IV, with 
cell processes or somata exhibiting both nestin- and GFAP-immunoreactivities. Double-
immunoreactive cell bodies had oval or fusiform shapes, and exhibited prominent, long 
slender processes that developed parallel to the wall of the lateral ventricle of anterior 
horn. In the body of ventricle, these processes appeared with no special organization. 
Nearly all nestin-positive cells expressed GFAP, and a major proportion of GFAP 
positive cells were also positive for nestin (Figure 4a-c). The few cells found positive 
for nestin with no astrocytic features were more abundant in the parenchyma, especially 
in stage VI of AD samples. 
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13 
In all control samples, double nestin-MAO-B immunohistochemistry revealed the 
presence of large cells with stellate morphology in layer III and in the hypocellular layer 
of the SVZ nearby blood vessels (Figure 4d-f). Some 35% of nestin-positive cells were 
also positive for MAO-B and a similar percent of MAO-B positive cells also expressed 
nestin. Fewer nestin/MAO-B-positive cells with a smaller round-shape were observed in 
AD samples. In all double-immunostained cells, labeling of nestin was mostly located 
in soma and MAO-B in soma and processes (Figure 4g-i), except in AD stage VI in 
which MAO-B was more localized in processes. Few double-immunostained round-
shape cells and unipolar and bipolar cells were also detected in the transitional zone and 
striatal parenchyma. Finally, nestin-immunoreactivity and HLA-DR-immunolabeling 
showed no co-localization. In the SVZ, HLA-DR positive cells were observed, mainly 
in layer III and IV. No spatial relationship between nestin-positive and HLA-DR-
positive cells was observed, except in AD samples where some HLA-DR positive cells 
surrounded nestin-positive cells (data not shown). 
 
DISCUSSION 
The present study gives evidence for the first time that MAO-B is expressed in SVZ 
progenitor cells of the human brain between 44 and 90 years. Morphological 
examination of the anterior horn and body of human lateral ventricle confirmed that 
adult human SVZ is organized into four specific layers (I-IV) with the SVZ astrocytes 
separated from the ependyma (I) by a hypocellular region (II) devoid of cells bodies. 
These astrocytes mainly localized in layer III, formed a cell ribbon before the 
transitional zone (IV) to parenchyma (Quinones-Hinojosa et al., 2006; Sanai et al., 
2004). Our data indicate an increase in progenitors in the SVZ during the course of AD. 
Neurogenesis in the SVZ is increased in acute neurological disorders, such as ischemia 
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14 
and epilepsy (Blumcke et al., 2001; Felling and Levison, 2003; Kokaia and Lindvall, 
2003) or in neurodegenerative disorders such as AD, Creutzfeldt-Jakob disease or brain 
tumors (Jackson and Alvarez-Buylla, 2008; Jin et al., 2004; Mizuno et al., 2006; 
Quinones-Hinojosa and Chaichana, 2007; Waldau and Shetty, 2008; Ziabreva et al., 
2006). In this study we found that expression of markers of radial cell differentiation is 
independent of neurodegeneration, in spite of the small deposition of Aprotein and 
microglial reaction present in layers I-IV of the germinal zone. 
According to previous immunohistochemical and enzyme-histochemical studies, 
MAO-B is localized in human brain astrocytes as well as in serotoninergic and 
histaminergic neurons of the raphe nuclei and posterior hypothalamus (Konradi et al., 
1988; Konradi et al., 1989). In this study, post-mortem delay ranged from 3 h to 19 h, 
and the sample time of storage prior to experiment ranged from 1 to 6 months. In these 
conditions, MAO-B remains a stable protein, and when present, its variation has been 
related with a cellular process. We and other authors have previously described a 
widespread increase of MAO-B expression in human brain aging, as a consequence of 
a general astroglial hypertrophy and/or hyperplasia (Nakamura et al., 1990; Saura et 
al., 1997; Saura et al., 1994). This astroglial up-regulation of MAO-B activity is 
closely related with AD senile plaques in cortical layers (Nakamura et al., 1990; Saura 
et al., 1997; Saura et al., 1994).  
However, the high expression of MAO-B in the SVZ in similar brain aging conditions, 
and its high level in ventricle ependyma, shown previously by quantitative MAO-B 
enzyme autoradiography (Saura et al., 1997) argue for a new cellular process, different 
from astrogliosis. Co-localization of MAO-B and nestin indicates the expression of a 
new marker of human adult SVZ, a zone that remains mitotically active in mammals 
throughout adult life (Alvarez-Buylla and Garcia-Verdugo, 2002; Merkle et al., 2004). 
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15 
The nestin/GFAP positive cells were abundant in SVZ layer III and organized as a 
continuous ribbon whereas nestin/MAO-B positive cells localized in layer III were less 
abundant and with no clear organization. Some nestin/MAO-B positive round-shaped 
cells and unipolar and bipolar cells were also detected in the transitional zone or layer 
IV of SVZ and brain parenchyma. In this portion of the germinal zone, MAO-B cellular 
localization appeared increased in the filaments in all the pathological cases, and more 
especially in the AD cases. The positive correlation between nestin/MAO B ratio and 
progression of the disease, and the increased nestin/GFAP ratio found in AD, could 
reflect the increased progenitor activity previously described in these patients (Ziabreva 
et al., 2006). Finally, the nestin positive cells lacking GFAP, that we found in SVZ and 
parenchyma in AD stage VI samples, could represent fully committed migrating 
neuroblasts (Kronenberg et al., 2003). 
GFAP and nestin have been the predominant markers used to describe stem and 
progenitor cells in mammalian CNS (Bernier et al., 2000; Doetsch et al., 1997; Doetsch 
et al., 1999; Ihrie and Alvarez-Buylla, 2008). In response to brain injury or 
degeneration, mature reactive GFAP positive astrocytes can express nestin and revert to 
embryonic phenotype of neuroepithelial stem cells (B rnier et al., 2000; Lin et al., 
1995). In our study, nearly all nestin-positive cells also express GFAP and but only 35% 
express MAO-B. The nestin/GFAP positive cells devoid of MAO-B may represent a 
distinct subpopulation that proliferates during an earlier phase of maturation. 
Dopamine-induced proliferation of precursor cells in the SVZ has been recently 
reported (O’Keeffe et al., 2009). As dopamine tissue content depends on MAO-B 
activity (Youdim et al., 2006), the increased MAO-B expression herein evidenced could 
be related to modulation of that progenitor cell proliferation. If true, MAO-B expression 
would take place in a further step of nestin/GFAP-positive cell maduration, to limit 
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16 
proliferation and facilitate the subsequent differentiation of progenitor cells. In the early 
AD stages, the increased nestin positive cells paralleled by a marked reduction of GFAP 
immunoreactivity evidences proliferation of progenitor cells and differentiation to 
neuroblasts (Kronenberg et al., 2003) or to newborn cells degenerated in the niche of 
germinal zone. In these conditions, the discrete MAO-B reduction, different from the 
severe GFAP decrease would reflect the capacity of progenitor cells to adapt to the 
neurodegenerative process at the SVZ level by increasing their differentiation rate. 
However, further investigation is required to decipher MAO-B participation in 
progenitor cells maturation and differentiation in control and neuropathological 
conditions. Anyhow, MAO-B labeling brings a new reliable tool for SVZ human stem 
cell study in control and pathological conditions. Finally, because of the marked 
differences between adult human and other vertebrates SVZ, our work highlights the 
importance of studying these cells in the human brain, especially when related to CNS 
diseases. 
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FIGURE LEGENDS  
Figure 1: Histological characterization of human SVZ in AD cases. (a, b) AD stage VI; 
Nissl staining showed the anterior horn region and body of ventricle region with a 
characteristic layer organization. The ependymal cells formed layer I, whereas layer II, 
a hypocellular region formed a gap with layer III that was organized as a dense ribbon 
of cell bodies. Finally layer IV represented a transitional zone to the striatal brain 
parenchyma. c) AD stage II; GFAP immunostaining of showed layer II as the most 
GFAP-immunoreactive area, with the GFAP immunopositive cell bodies localized in 
layer III. d) AD stage VI; nestin immunopositive cells were localized mainly in layer III 
(arrowheads) sometimes formed small chains, with short processes oriented radially to 
the hypocellular layer. e) AD stage II; scarcely activated microglial cells detected by 
HLA-DR immunohistochemistry were found mainly in the layer II (arrowhead). 
Microglial positive cells were also detected in the trans tional zone (asterisk) (Layer IV) 
and brain parenchyma. f) AD stage II; cerebral A protein deposition was practically 
absent in the human SVZ, except in AD stage VI cases where small amyloid deposits 
were detected in layer III. In AD cases amyloid-beta deposition was abundantly present 
in the brain parenchyma. LV: Lateral ventricle. Scale bar: a-e 50 m;  f, 200 m  
 
Figure 2: Evidences of MAO-B localization in the SVZ of AD cases. (a) Quantitative 
[3H]lazabemide in vitro autoradiography of human basal ganglia samples evidenced the 
highest brain MAO-B labeling in the SVZ (arrow) (Results extracted from Saura et al. 
1997). (b) AD stage V; histochemistry showed MAO-B activity labeling in the SVZ, 
Page 46 of 53
Journal of Neuroscience Research
Journal of Neuroscience Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
23 
especially in astrocytes of layer III (arrows and inset). (c) AD stage V; MAO-B 
immunohistochemistry counterstained with haematoxylin (cellular nuclei stained in 
blue) in the SVZ and parenchyma evidenced MAO-B staining (brown) in the cells with 
astrocyte morphology. (d) MAO-B western blot analysis of the SVZ and striatal 
parenchyma (parem) brain samples. (e-h) Scater plot and histograms of cell counts from 
the different markers included in the study, in control subjects (n= 3) and AD subjects 
(n= 7). Note the different AD-induced change between Nestin positive cell count and 
GFAP or MAO-B positive cell counts. LV: Lateral ventricle. AD, Alzheimer’s disease. 
Scale bars: a, 3 mm, b, 50 m; c and inset in b, 15 m * p< 0.05;  ** p<0.01;  *** 
p<0.001 vs. control (LSD post-hoc). 
 
Figure 3: Estimation of the AD changes in the relationship between Nestin, GFAP, 
MAO-B, and HLA-DR positive cell counts in the SVZ. The ratio estimation and 
dispersion plot of Nestin/GFAP (a,b), Nestin/MAO-B (c,d), GFAP/MAO-B (e,f), and 
Nestin/HLA-DR (g,h) immunopositive cells evidenced an AD-associated decrease of 
GFAP-immunopositive cells with respect to both Nestin and MAO-B positive cells. 
Please note an AD-stage associated increase of nestin positive cells (r2=0.593, p= 
0.038) in dispersion plots b, d and h. AD, Alzheimer’s disease; Stage II and Stage V-VI 
refers to Stages of AD cases. * p< 0.05; vs. control (LSD post-hoc). 
 
Figure 4: Co-localization of SVZ markers of AD cases. (a-c) AD stage V; the double 
confocal immunohistochemistry of body of ventricle showing GFAP in green and nestin 
in red, revealed the presence of oval or fusiform astrocyte-like cells mostly in layer III 
(merge), with positive large and extensive with no special organization. (d-f) AD stage 
VI; the double confocal nestin (red) / MAO-B (green) immunohistochemistry revealed 
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24 
the presence of round-shape cells and unipolar and bipolar cells in layer III and the 
transitional zone and striatal brain parenchyma (merge) especially in AD samples. (g-i) 
In control samples the presence of nestin (red) / MAO-B (green) positive large cells 
with stellate morphology were detected in layer III and in the hypocellular layer nearby 
blood vessels (merge). Scale bar:a-fm;  g-i, 16 m.  
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1 
 
Table 1: Summary of case histories and cellular composition of the adult human SVZ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M=male; F=female; AD: Alzheimer’s disease; MAO-B positive data are from immunohistochemistry study; values are expressed as meanSD 
 Case nº Age 
(years) 
Sex Post-mortem 
delay (hours) 
Neuropathological  
diagnosis  
Nestin 
positive 
cells/mm2 
GFAP 
positive 
cells/mm2 
MAO-B  
positive 
cells/mm2 
HLA-DR  
positive 
cells/mm2 
          
1. BK 331 44 M 6.0 Control 160  11 187  51 117  28 86  19 
2. BK 380 72 F 6.0 Control 160  12 193  73 120  10 79  21 
3. BK 499 74 F 3.40 Control 157  28 187  56 117  25 76  22 
          
4. BK 470 82 F 5.45 AD stage II 180  45 70  26 90  10 89  15 
5. BK 542 79 F 5.0 AD stage II  180  30 77  15 93  28 75  15 
6. BK 569 88 F 4.0 AD Stage II  187  35 53  25 101  10 84  4 
7. BK 731 91 M 7.0 AD stage V 150  45 93  11 100  26 67  16 
8. BK 647 90 F 18.50 AD stage VI 253  35 123  25 93  5 71  10 
9. BK 725 81 M 7.30 AD stage VI 313  72 83  15 107  11 83  12 
10. BK 729 77 F 14.0 AD stage VI 260  20 80  26 88  10 74  8 
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

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

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


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